125 related articles for article (PubMed ID: 17331550)
21. Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.
Drotschmann K; Clark AB; Tran HT; Resnick MA; Gordenin DA; Kunkel TA
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2970-5. PubMed ID: 10077621
[TBL] [Abstract][Full Text] [Related]
22. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
23. Class switch recombination efficiency and junction microhomology patterns in Msh2-, Mlh1-, and Exo1-deficient mice depend on the presence of mu switch region tandem repeats.
Eccleston J; Schrader CE; Yuan K; Stavnezer J; Selsing E
J Immunol; 2009 Jul; 183(2):1222-8. PubMed ID: 19553545
[TBL] [Abstract][Full Text] [Related]
24. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
[TBL] [Abstract][Full Text] [Related]
25. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
26. The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model.
Ezzatizadeh V; Pinto RM; Sandi C; Sandi M; Al-Mahdawi S; Te Riele H; Pook MA
Neurobiol Dis; 2012 Apr; 46(1):165-71. PubMed ID: 22289650
[TBL] [Abstract][Full Text] [Related]
27. Quantifying Microsatellite Mutation Rates from Intestinal Stem Cell Dynamics in Msh2-Deficient Murine Epithelium.
Christopher J; Thorsen AS; Abujudeh S; Lourenço FC; Kemp R; Potter PK; Morrissey E; Hazelwood L; Winton DJ
Genetics; 2019 Jul; 212(3):655-665. PubMed ID: 31126976
[TBL] [Abstract][Full Text] [Related]
28. Ionising radiation and mutation induction at mouse minisatellite loci. The story of the two generations.
Dubrova YE; Plumb MA
Mutat Res; 2002 Feb; 499(2):143-50. PubMed ID: 11827707
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
30. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.
Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J;
Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137
[TBL] [Abstract][Full Text] [Related]
31. Expanded simple tandem repeat (ESTR) mutation induction in the male germline: lessons learned from lab mice.
Somers CM
Mutat Res; 2006 Jun; 598(1-2):35-49. PubMed ID: 16500683
[TBL] [Abstract][Full Text] [Related]
32. Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene.
Pineda M; Castellsagué E; Musulén E; Llort G; Frebourg T; Baert-Desurmont S; González S; Capellá G; Blanco I
Genes Chromosomes Cancer; 2008 Apr; 47(4):326-32. PubMed ID: 18181177
[TBL] [Abstract][Full Text] [Related]
33. Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner.
Sansom OJ; Toft NJ; Winton DJ; Clarke AR
Oncogene; 2001 Jun; 20(27):3580-4. PubMed ID: 11429706
[TBL] [Abstract][Full Text] [Related]
34. No correlation between germline mutation at repeat DNA and meiotic crossover in male mice exposed to X-rays or cisplatin.
Barber R; Plumb M; Smith AG; Cesar CE; Boulton E; Jeffreys AJ; Dubrova YE
Mutat Res; 2000 Dec; 457(1-2):79-91. PubMed ID: 11106800
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
36. The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model.
Lokanga RA; Zhao XN; Usdin K
Hum Mutat; 2014 Jan; 35(1):129-36. PubMed ID: 24130133
[TBL] [Abstract][Full Text] [Related]
37. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
[TBL] [Abstract][Full Text] [Related]
38. Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation.
Jeans AF; Frayling I; Jasani B; Side L; Blesing C; Ansorge O
Nat Rev Clin Oncol; 2009 May; 6(5):295-9. PubMed ID: 19390556
[TBL] [Abstract][Full Text] [Related]
39. Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations.
Buecher B; De Pauw A; Bazire L; Houdayer C; Fievet A; Moncoutier V; Farkhondeh F; Melaabi S; Lyonnet DS; Golmard L
Fam Cancer; 2018 Apr; 17(2):281-285. PubMed ID: 28819700
[TBL] [Abstract][Full Text] [Related]
40. Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice.
Winter JM; Hu Y; Young GP; Kohonen-Corish MR; Le Leu RK
J Nutrigenet Nutrigenomics; 2014; 7(4-6):299-313. PubMed ID: 26022687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
